COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Patient Preference in Blood Pressure Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03548623
Recruitment Status : Completed
First Posted : June 7, 2018
Last Update Posted : February 18, 2020
Institute for Preventive Medicine
Information provided by (Responsible Party):
Roland E. Schmieder, University of Erlangen-Nürnberg Medical School

Brief Summary:

Written surveys of patients with high blood pressure are designed to determine how they would likely decide if, in addition to taking medication, they had another option to treat their hypertension.

The alternative treatment option is renal sympathetic denervation using catheter ablation. This new treatment method is not yet used in the standard care. Currently, studies are being conducted in specific centers to demonstrate the efficacy of this treatment.

Questionnaires are used to determine the preference of patients for one or the other option of hypertension treatment. So far, there are no findings.

Condition or disease
Arterial Hypertension

Layout table for study information
Study Type : Observational
Actual Enrollment : 1000 participants
Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: Patient Preference in Blood Pressure Therapy: Questioning of Patients With Hypertension
Actual Study Start Date : May 1, 2017
Actual Primary Completion Date : April 30, 2018
Actual Study Completion Date : October 31, 2018

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. Preference of treatment [ Time Frame: 3 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
  • male and female
  • > 18 years

Inclusion Criteria:

  • untreated Hypertension
  • treated Hypertension with one or more medications

Exclusion Criteria:

  • illiteracy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03548623

Layout table for location information
Institute for Preventive Medicine
Nuremberg, Germany, 90471
Sponsors and Collaborators
Roland E. Schmieder
Institute for Preventive Medicine
Layout table for additonal information
Responsible Party: Roland E. Schmieder, Full Professor of Medicine, University of Erlangen-Nürnberg Medical School Identifier: NCT03548623    
Other Study ID Numbers: CRC2017PPiB
First Posted: June 7, 2018    Key Record Dates
Last Update Posted: February 18, 2020
Last Verified: February 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Roland E. Schmieder, University of Erlangen-Nürnberg Medical School:
renal denervation
shared decision making
Additional relevant MeSH terms:
Layout table for MeSH terms
Vascular Diseases
Cardiovascular Diseases